4'-(methylsulfonyl)-2-(trifluoromethyl)-[1,1'-biphenyl]-4-amine

Catalog No. :
ACOEVK058
CAS No. :
1628015-18-8
Molecular Formula :
C14H12F3NO2S
Molecular Weight :
315.32

IUPAC Name:4'-(methylsulfonyl)-2-(trifluoromethyl)-[1,1'-biphenyl]-4-amine

4'-(methylsulfonyl)-2-(trifluoromethyl)-[1,1'-biphenyl]-4-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$1232.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4'-(methylsulfonyl)-2-(trifluoromethyl)-[1,1'-biphenyl]-4-amine
IUPAC Name4'-(methylsulfonyl)-2-(trifluoromethyl)-[1,1'-biphenyl]-4-amine
Molecular FormulaC14H12F3NO2S
Molecular Weight315.32
SMILESCS(=O)(=O)C1=CC=C(C2=C(C(F)(F)F)C=C(N)C=C2)C=C1
InChI KeyCUSDIJRQJUNPIC-UHFFFAOYSA-N
Synonym[1,1'-Biphenyl]-4-amine, 4'-(methylsulfonyl)-2-(trifluoromethyl)-;4-(4-Methylsulfonylphenyl)-3-(trifluoromethyl)aniline;4'-(Methylsulfonyl)-2-(trifluoromethyl)-[1,1'-biphenyl]-4-amine;4'-(Methylsulfonyl)-2-(trifluoromethyl)[1,1'-biphenyl]-4-amine
CAS No.1628015-18-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACOEVK058 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPEHV593 route compound structure diagram
    ACPEHV593149104-88-1 In Stock
  2. Plus
  3. ACXGPE392 route compound structure diagram
    ACXGPE392393-36-2 In Stock
  4. Then
  5. ACOEVK058 route product structure diagram
    ACOEVK0581628015-18-8
Inquiry

2. ACOEVK058 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOEVK058 route product structure diagram
    ACOEVK0581628015-18-8
Inquiry

Comments (0)